Read Time:8 Second
Results of a clinical trial point to a stable future for Eisai and Biogen’s lecanemab once the therapy is approved by the Food and Drug Administration.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0